$LCTX News

Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject’ Cell Therapy Plan

Lineage Cell Therapeutics, Inc. (LCTX) Discusses COR1 Cell Transplant Program and Manufacturing Strategy for Corneal Endothelial Disease Transcript

Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

Lineage Cell Therapeutics Updates COR1 Corneal Cell Transplant Program; Highlights Scalable Allogeneic Production Via AlloSCOPE Platform And Plans Conference Call Today

Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit

Transcript: Lineage Cell Therapeutics Q1 2026 Earnings Conference Call

Lineage Cell Therapeutics (LCTX) Stock Faces Mixed Analyst Target Changes After Fresh Coverage

How The Lineage Cell Therapeutics (LCTX) Story Is Shifting With New Data And Analyst Targets

Lineage Cell Therapeutics Q1 Earnings Call Highlights

Lineage Cell Therapeutics Inc (LCTX) Q1 2026 Earnings Call Highlights: Strategic Advances and ...

Lineage Cell Therapeutics, Inc. (LCTX) Q1 2026 Earnings Call Transcript

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates

Lineage Cell Therapeutics (NYSEARCA:LCTX) Q1 2026 Results: Revenue Miss and Increased Losses Weigh on Investor Sentiment

Lineage Cell Therapeutics Q1 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.725M Miss $3.602M Estimate

Lineage Cell Therapeutics, Inc. (LCTX) Presents at FFB Retinal Therapeutics Innovation Summit - Slideshow

Niagen Bioscience And 2 Additional Promising Penny Stocks For Your Consideration

Lineage Announces Formation of Scientific Advisory Board

Lineage Cell (LCTX) Launches Its Latest Cell Therapy Program

Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease

HC Wainwright & Co. Reiterates Buy on Lineage Cell Therapeutics, Maintains $9 Price Target